People (32,083)
Mark A. Kay, M.D., Ph.D.
Tenaya Therapeutics
team_member
Mark A. Smith, MD, PhD
Neuphoria Therapeutics
team_member
Mark Adams
Mark Adams, Ph.D.Partner at Two Bear CapitalLinkedInRead more
Talus Bioscience
team_member
Mark Adler
Canary Medical
team_member
Mark Agne
Silver Creek Pharmaceuticals
team_member
Mark Altmeyer
Chair person
Calluna Pharma
board_chair
Mark Altmeyer, M.B.A.
Alector
team_member
Mark Alvino
Abeona Therapeutics
team_member
Mark Anderson
Mark Anderson, M.D., Ph.D.Executive Vice President for Medical Affairs, Dean of the Division of the Biological Sciences, Dean of the Pritzker School of Medicine, University of Chicago
Cardurion Pharmaceuticals
team_memberexecutive
Mark Anderson
SINTX Technologies
team_member
Mark Andrews
Torbay Pharmaceuticals
team_member
Mark Angelicola, M.S.
Biohaven
team_member
Mark Arnold
Mark Arnold
ZAP Surgical
team_member
Mark Avagliano
Georgiamune
team_member
Mark Awadalla
Chief Development Officer
Capricor Therapeutics
team_member
Mark B
Mark B. McClellan
Johnson and Johnson
team_member
Mark B
Mark B. McClellan
Johnson and Johnson Innovative Medicine
team_member
Mark Bach, MD, PhD
Chief Medical Officer
Beckman Coulter Diagnostics
executive